UPDATED Aug 18, 2022
Discover large cap Taiwanese Healthcare companies that are on the TAIEX. These Healthcare Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 6491Pegavision | NT$414.00 | 1.3% | -18.0% | NT$29.0b | NT$514.00 | PE20.3x | E21.1% | 2.1% | ||
| 3218Universal Vision Biotechnology | NT$339.00 | 5.0% | 12.8% | NT$26.6b | NT$391.25 | PE35.9x | E31.2% | 1.5% | ||
| 4736TaiDoc Technology | NT$211.50 | 8.5% | 4.7% | NT$19.3b | NT$250.00 | PE6.4x | E-46.9% | 7.1% | ||
| 6782Visco Vision | NT$339.50 | 6.6% | 185.3% | NT$18.6b | n/a | PE31.3x | n/a | 1.2% | ||
| 1565St.Shine OpticalLtd | NT$278.00 | 3.3% | -16.5% | NT$14.0b | NT$288.57 | PE13.4x | E4.3% | 5.4% | ||
| 4104Excelsior Medical | NT$67.00 | 2.0% | 22.9% | NT$9.5b | NT$56.00 | PE14.6x | n/a | 5.2% | ||
| 4107Bioteque | NT$114.00 | 3.2% | 8.1% | NT$7.8b | NT$129.00 | PE16.9x | n/a | 3.9% | ||
| 4164CHC Healthcare Group | NT$44.50 | 6.7% | 34.0% | NT$7.2b | NT$50.00 | PE19.2x | E32.7% | 4.5% | ||
| 4771Vizionfocus | NT$130.00 | 6.6% | n/a | NT$6.8b | n/a | PE28.9x | n/a | 1.2% | ||
| 1788Hi-Clearance | NT$158.50 | 1.3% | 19.6% | NT$6.4b | n/a | PE16.5x | n/a | 4.4% | ||
| 6762Delta Asia International | NT$213.00 | 2.4% | -15.6% | NT$5.5b | n/a | PE48.2x | n/a | 1.2% | ||
| 4737Bionime | NT$87.80 | 8.7% | 24.0% | NT$5.3b | n/a | PE46.2x | n/a | 2.3% | ||
| 6499Medeon Biodesign | NT$72.70 | 5.8% | 8.4% | NT$5.3b | NT$106.00 | PS22.2x | n/a | 1.4% | ||
| 6747Brighten Optix | NT$217.50 | 0.5% | -13.0% | NT$5.2b | NT$300.76 | PE21.8x | S23.2% | 4.0% | ||
| 6841Ever Fortune.AI | NT$58.00 | -8.4% | n/a | NT$5.1b | n/a | PS261.1x | n/a | n/a | ||
| 4126Pacific Hospital Supply | NT$68.50 | 0.9% | -2.0% | NT$5.0b | NT$73.00 | PE13.8x | E-7.5% | 6.6% | ||
| 4163INTAI Technology | NT$93.20 | 3.1% | 13.7% | NT$4.5b | n/a | PE13.8x | n/a | 2.7% | ||
| 8403ShareHope Medicine | NT$36.70 | 8.7% | 43.5% | NT$4.0b | n/a | PE11.7x | n/a | 1.4% | ||
| 6796Medimaging Integrated Solution | NT$116.00 | 1.3% | 81.0% | NT$3.8b | n/a | PE53.7x | n/a | 1.4% | ||
| 6879TCI GENE | NT$135.00 | -5.9% | n/a | NT$3.6b | n/a | PE38.6x | n/a | 1.5% | ||
| 4171GeneReach Biotechnology | NT$84.70 | 14.9% | -21.4% | NT$3.5b | n/a | PE8.6x | n/a | 5.9% | ||
| 4116BenQ Medical Technology | NT$76.70 | 8.8% | 172.0% | NT$3.4b | n/a | PE23.9x | n/a | 0.7% | ||
| 6569Onyx Healthcare | NT$96.60 | 0.3% | -17.6% | NT$3.2b | n/a | PE19.5x | n/a | 4.1% | ||
| 1786SciVision Biotech | NT$43.00 | 2.9% | -13.6% | NT$2.8b | n/a | PE25.4x | n/a | 3.3% |